Prevalence of celiac disease among dyspeptic patients: A community-based case-control study

Turkish Journal of Gastroenterology

Volumn 19, Issue 2, 2008, Pages 81-84

  Altintaş, Engin ^a,b   Şenli, Mehmet S ^a   Sezgin, Orhan ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Celiac disease; Dyspepsia; Tissue transglutaminase antibody

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DUODENUM BIOPSY; DYSPEPSIA; ENDOSCOPIC BIOPSY; ENTEROPATHY; FEMALE; HISTOPATHOLOGY; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELIAC DISEASE; COMORBIDITY; DUODENAL DISEASES; DUODENUM; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; TRANSGLUTAMINASES; TURKEY; YOUNG ADULT;

EID: 45849135218     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003; 1: 19-27.
2. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960-5.
3. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-24.
4. Tatar G, Elsurer R, Simsek H, et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci 2004; 49: 1479-84.
5. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
6. Susie K, Lee HR, Peter HR, et al. Celiac sprue (the great modern-day imposter). Curr Opin Rheumatology 2006; 18: 101-7.
7. Lo W, Sano K, Lebwohl B, et al. Changing presentation of adult celiac disease. Dig Dis Sci 2003; 48: 395-8.
8. Bardella MT, Minoli G, Ravizza D, et al. Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med 2000; 160: 1489-91.
9. Ciacci C, Cirillo M, Sollazzo R, et al. Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol 1995; 30: 1077-81.
10. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346: 180-8.
11. Nelsen DA Jr. Gluten-sensitive enteropathy (celiac disease): more common than you think. Am Fam Physician 2002; 66: 2259-66.
12. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45: 37-42.
13. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992; 102: 330-54.
14. Fisher LD, Dixon DO, Herson J, et al. Intention to treat in clinical trials. In: Pearce KE, ed. Statistical issues in drug research and development. New York: Marcel Dekker, 1990; 331-50.
15. Gore SM, Jones G, Thompson SG. The Lancet's statistical review process: areas for improvement by authors. Lancet 1992; 340: 100-2.
16. National Institutes of Health. Statement. NIH Consensus Development Conference on Celiac Disease, 2004.
17. Niveloni S, Fiorini A, Dezi R, et al. Usefulness of videoduodenoscopy and vital dye staining as indicators of mucosal atrophy of celiac disease: assessment of interobserver agreement. Gastrointest Endosc 1998; 47: 223-9.
18. Smith AD, Graham I, Rose JDR. A prospective endoscopic study of scalloped folds and grooves in the mucosa of the duodenum as signs of villous atrophy. Gastrointest Endosc 1998; 47: 461-5.
19. Dickey W, Hughes D. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol 2001; 96: 2126-8.
20. Basso D, Gallo N, Guariso G, et al. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination. J Clin Lab Anal 2001; 15: 112-5.
21. Shamir R, Lerner A, Shinar E, et al. The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Am J Gastroenterol 2002; 97: 2589-94.
22. Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995; 30: 519-23.
23. Dickey W, Hughes D. Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol 1999; 94: 2182-6.
24. Collin P, Rasmussen M, Kyrönpalo S, et al. The hunt for coeliac disease in primary care. Q J Med 2002; 95: 75-7.
25. Vivas S, Ruiz de Morales JM, Martinez J, et al. Human recombinant antitransglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients. Eur J Gastroenterol Hepatol 2003; 15: 479-83.
26. Lima VM, Gandolfi L, Pires JAA, et al. Prevalence of celiac disease in dyspeptic patients. Arq Gastroenterol 2005; 42: 153-6.
27. Karaaslan H, Bektaş M, Bozkaya H, et al. Gönüllü Kan Donörlerinde Gluten Enteropatisi Seroprevalansi. 20. Ulusal Gastroenteroloji Haftasi Bildiri Kitapçiǧi; SB. 03/6 sayfa: 18.
28. Yenice N, Gümrah M, Kozan A. Asemptomatik bireylerde gluten sensitif enteropati Seroprevalansi. Akademik Gastroenteroloji Dergisi 2005; 4: 94-6.